SCHEMBL1106523

SCHEMBL1106523

CC(C)N1CCOC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1106517 0.86 PIK3CD (0.53)
SCHEMBL10245854 0.85 PIK3CD (0.47)
SCHEMBL14967979 0.84
SCHEMBL4200299 0.82
SCHEMBL23917674 0.82
SCHEMBL23663784 0.82 KDM4E (0.49)
SCHEMBL24568176 0.82 KDM4E (0.49)
SCHEMBL16044897 0.82
SCHEMBL23269830 0.82
SCHEMBL11201426 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 466 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4646405-A1 PROCESS FOR PREPARING AN N-SUBSTITUTED-2-OXAZOLIDINONE Huntsman Petrochemical LLC (US) 2025-11-12 EP claimed
WO-2024147895-A1 PROCESS FOR PREPARING AN N-SUBSTITUTED-2-OXAZOLIDINONE HUNTSMAN PETROCHEMICAL LLC (US) 2024-07-11 WO claimed
CN-117038905-A Composite manganese-based positive electrode material, preparation method thereof and lithium ion battery 蜂巢能源科技股份有限公司 2023-11-10 CN claimed
EP-2771337-A1 3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH Novartis AG (CH) 2014-09-03 EP claimed
WO-2013046136-A1 3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH NOVARTIS AG (CH) 2013-04-04 WO claimed
WO-2008119734-A2 PROCESS FOR THE MANUFACTURE OF ORGANIC COMPOUNDS NOVARTIS AG (CH) 2008-10-09 WO claimed
US-6617483-B1 Extractive distillation for separating a mixture of hydrocarbons with an alkylene glycol and a compatibility agent having polar parameters and hydrogen bonding parameters that result in improved separation GAYLORD CHEMICAL CORPORATION 2003-09-09 US claimed
EP-0594608-B1 CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS RES CORP TECHNOLOGIES INC (US) 1997-10-15 EP claimed
EP-0594608-A1 CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS. RES CORP TECHNOLOGIES INC (US) 1994-05-04 EP claimed
EP-0594608-A4 CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS. RES CORP TECHNOLOGIES INC (US) 1993-03-15 EP claimed
WO-1991014672-A1 CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESIS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1991-10-03 WO claimed
EP-4646405-A1 PROCESS FOR PREPARING AN N-SUBSTITUTED-2-OXAZOLIDINONE Huntsman Petrochemical LLC (US) 2025-11-12 EP disclosed
WO-2025224179-A1 GLUTAMINYL CYCLASE INHBITORS FOR USE IN THE TREATMENT OF KIDNEY DISEASE VIVORYON THERAPEUTICS N.V. (DE) 2025-10-30 WO disclosed
US-12312419-B2 Hemiasterlin derivative having cysteine residue Sumitomo Pharma Co., Ltd. (JP) 2025-05-27 US disclosed
US-12178879-B2 Hemiasterlin derivative and antibody-drug conjugate thereof Sumitomo Pharma Co., Ltd. (JP) 2024-12-31 US disclosed
EP-0329360-A2 Pyridine derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-08-23 EP disclosed
EP-0244810-A1 Process for producing 2-oxazolidinones MITSUI TOATSU CHEMICALS, Inc. (JP) 1987-11-11 EP disclosed
US-4473501-A HYPOTENSIVES G. D. SEARLE & CO. (US) 1984-09-25 US disclosed
EP-0008711-B1 A METHOD OF PREPARING A 2-HYDROXY-3-ISOPROPYL OR A 2-HYDROXY-3-TERT-BUTYLAMINOPROPYL AROMATIC ETHER SMITHKLINE BECKMAN CORPORATION (US) 1981-11-04 EP disclosed
EP-0008711-A1 A method of preparing a 2-hydroxy-3-isopropyl or a 2-hydroxy-3-tert-butylaminopropyl aromatic ether SMITHKLINE BECKMAN CORPORATION (US) 1980-03-19 EP disclosed